Aliases & Classifications for Gestational Trophoblastic Neoplasm

MalaCards integrated aliases for Gestational Trophoblastic Neoplasm:

Name: Gestational Trophoblastic Neoplasm 12 14
Hydatidiform Mole 12 41 69
Gestational Trophoblastic Disease 41 69
Gestational Trophoblastic Neoplasia 12
Gestational Trophoblastic Neoplasms 69
Hydatidiform Mole, Recurrent, 1 69
Molar Pregnancy 12

Classifications:



Summaries for Gestational Trophoblastic Neoplasm

MalaCards based summary : Gestational Trophoblastic Neoplasm, also known as hydatidiform mole, is related to hydatidiform mole, recurrent, 1 and choriocarcinoma, and has symptoms including spontaneous abortion, high maternal serum chorionic gonadotropin and menometrorrhagia. An important gene associated with Gestational Trophoblastic Neoplasm is NLRP7 (NLR Family Pyrin Domain Containing 7), and among its related pathways/superpathways is Nucleotide-binding Oligomerization Domain (NOD) pathway. The drugs Nitroglycerin and Chorionic Gonadotropin have been mentioned in the context of this disorder. Affiliated tissues include bone, bone marrow and breast.

Related Diseases for Gestational Trophoblastic Neoplasm

Diseases related to Gestational Trophoblastic Neoplasm via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 30)
# Related Disease Score Top Affiliating Genes
1 hydatidiform mole, recurrent, 1 32.2 CDKN1C KHDC3L NLRP7 PHLDA2
2 choriocarcinoma 30.0 CDKN1C CSH1 CSH2
3 trophoblastic neoplasm 29.9 CDKN1C CSH1 KHDC3L NLRP2 NLRP7 NR0B1
4 gestational trophoblastic tumor 11.4
5 placental site trophoblastic tumor 11.2
6 partial hydatidiform mole 10.5 KHDC3L NLRP7
7 triploidy 10.5 KHDC3L NLRP7
8 pyle disease 10.3 CDKN1C NR0B1
9 intrauterine growth retardation, metaphyseal dysplasia, adrenal hypoplasia congenita, and genital anomalies 10.2 CDKN1C NR0B1
10 testicular trophoblastic tumor 10.1 CSH1 CSH2
11 testicular granulosa cell tumor 10.1 CSH1 CSH2
12 choriocarcinoma of ovary 10.1 CSH1 CSH2
13 juvenile type testicular granulosa cell tumor 10.1 CSH1 CSH2
14 non-gestational choriocarcinoma 10.1 CSH1 CSH2
15 choriocarcinoma of the testis 10.1 CSH1 CSH2
16 adrenocortical carcinoma, hereditary 10.1 CDKN1C NR0B1
17 rh isoimmunization 10.0 CSH1 CSH2
18 breast metaplastic carcinoma 10.0 CSH1 CSH2
19 chronic salpingitis 10.0 CSH1 CSH2
20 uterine anomalies 10.0 CSH1 CSH2
21 beckwith-wiedemann syndrome 10.0 CDKN1C NLRP2 PHLDA2
22 placenta disease 9.9 CSH1 CSH2
23 klippel-trenaunay-weber syndrome 9.9
24 pleurisy 9.9
25 hypothyroidism 9.9
26 epithelioid trophoblastic tumor 9.9
27 placenta accreta 9.9
28 diabetes mellitus, transient neonatal, 1 9.8 HYMAI KHDC3L NLRP2 NLRP7
29 female reproductive system disease 9.7 CSH1 CSH2
30 germ cell and embryonal cancer 8.8 CDKN1C CSH1 CSH2 KHDC3L LGALS1 NLRP7

Graphical network of the top 20 diseases related to Gestational Trophoblastic Neoplasm:



Diseases related to Gestational Trophoblastic Neoplasm

Symptoms & Phenotypes for Gestational Trophoblastic Neoplasm

Human phenotypes related to Gestational Trophoblastic Neoplasm:

31
# Description HPO Frequency HPO Source Accession
1 spontaneous abortion 31 hallmark (90%) HP:0005268
2 high maternal serum chorionic gonadotropin 31 hallmark (90%) HP:0011433
3 menometrorrhagia 31 hallmark (90%) HP:0400008

Drugs & Therapeutics for Gestational Trophoblastic Neoplasm

Drugs for Gestational Trophoblastic Neoplasm (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 177)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nitroglycerin Approved, Investigational Phase 4,Phase 2 55-63-0 4510
2 Chorionic Gonadotropin Phase 4
3
Levoleucovorin Approved, Investigational Phase 2, Phase 3 68538-85-2
4
Methotrexate Approved Phase 2, Phase 3 1959-05-2, 59-05-2 126941
5
Dactinomycin Approved, Investigational Phase 3,Phase 2 50-76-0 457193 2019
6
Amifostine Approved, Investigational Phase 3 20537-88-6 2141
7
Amphotericin B Approved, Investigational Phase 3 1397-89-3 5280965 14956
8
Caspofungin Approved Phase 3,Phase 2 162808-62-0, 179463-17-3 2826718 468682
9
Miconazole Approved, Investigational, Vet_approved Phase 3,Phase 2 22916-47-8 4189
10
Captopril Approved Phase 3 62571-86-2 44093
11
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
12
Palivizumab Approved, Investigational Phase 3 188039-54-5
13
Ribavirin Approved Phase 3 36791-04-5 37542
14
Fluconazole Approved, Investigational Phase 3 86386-73-4 3365
15
Itraconazole Approved, Investigational Phase 3 84625-61-6 55283
16
Carboplatin Approved Phase 3,Phase 1 41575-94-4 10339178 38904 498142
17
Etoposide Approved Phase 3,Phase 1 33419-42-0 36462
18
Cisplatin Approved Phase 3 15663-27-1 2767 441203 84093
19
Paclitaxel Approved, Vet_approved Phase 3 33069-62-4 36314
20
Vincristine Approved, Investigational Phase 3 2068-78-2, 57-22-7 5978
21
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
22
Ethinyl Estradiol Approved Phase 3 57-63-6 5991
23
Moxifloxacin Approved, Investigational Phase 3 151096-09-2, 354812-41-2 152946
24
Norgestimate Approved, Investigational Phase 3 35189-28-7 6540478
25
Mycophenolate mofetil Approved, Investigational Phase 3 128794-94-5 5281078
26
Mycophenolic acid Approved Phase 3 24280-93-1 446541
27
Folic Acid Approved, Nutraceutical, Vet_approved Phase 2, Phase 3,Phase 3,Not Applicable 59-30-3 6037
28
leucovorin Approved, Nutraceutical Phase 2, Phase 3,Phase 3,Not Applicable 58-05-9 143 6006
29 Antidotes Phase 2, Phase 3
30 Antimetabolites Phase 2, Phase 3
31 Antimetabolites, Antineoplastic Phase 2, Phase 3
32 Antirheumatic Agents Phase 2, Phase 3,Phase 3,Not Applicable
33 Bone Density Conservation Agents Phase 2, Phase 3
34 Calcium, Dietary Phase 2, Phase 3
35 Dermatologic Agents Phase 2, Phase 3
36 Folic Acid Antagonists Phase 2, Phase 3
37 Hematinics Phase 2, Phase 3,Phase 3,Not Applicable
38 Immunosuppressive Agents Phase 2, Phase 3, Phase 1
39 Liver Extracts Phase 2, Phase 3, Phase 1
40 Micronutrients Phase 2, Phase 3,Phase 3,Not Applicable
41 Nucleic Acid Synthesis Inhibitors Phase 2, Phase 3
42 Protective Agents Phase 2, Phase 3
43 Trace Elements Phase 2, Phase 3,Phase 3,Not Applicable
44 Vitamin B Complex Phase 2, Phase 3,Phase 3,Not Applicable
45 Vitamins Phase 2, Phase 3,Phase 3,Not Applicable
46 Anti-Bacterial Agents Phase 3,Phase 2,Phase 1
47 Antibiotics, Antitubercular Phase 3,Phase 2
48 Anti-Infective Agents Phase 3,Phase 2,Phase 1
49 Radiation-Protective Agents Phase 3
50 Antifungal Agents Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 74)

# Name Status NCT ID Phase Drugs
1 Conformation of Beta Human Chorionic Gonadotropin During Chemotherapy for Choriocarcinoma Unknown status NCT00294177 Phase 4
2 A Comparison of Single Versus Double Evacuation for Treatment of Hydatidiform Mole Recruiting NCT01630954 Phase 4
3 Surgery Plus Single Agent Chemotherapy Versus Primary Chemotherapy for Gestational Trophoblastic Neoplasms Unknown status NCT02606539 Phase 2, Phase 3 Methotrexate plus folinic acid alone
4 Methotrexate Compared With Dactinomycin in Treating Patients With Gestational Trophoblastic Neoplasia Completed NCT00003702 Phase 3 Methotrexate
5 RCT on the Efficacy of Methotrexate for the Prevention of GTD Completed NCT01984099 Phase 3 Methotrexate;Vitamin B Complex
6 Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Cancer Completed NCT00058071 Phase 3 amifostine trihydrate
7 Music Therapy or Book Discussion in Improving Quality of Life in Young Patients Undergoing Stem Cell Transplant Completed NCT00305851 Phase 3
8 Caspofungin Acetate Compared With Amphotericin B Liposomal in Treating Patients With Persistent Fever and Neutropenia Following Cancer Treatment Completed NCT00008359 Phase 3 caspofungin acetate;liposomal amphotericin B
9 Captopril in Treating Patients Undergoing Bone Marrow or Stem Cell Transplantation Completed NCT00004230 Phase 3 captopril;cyclophosphamide
10 Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation Completed NCT00014391 Phase 3 ribavirin
11 Liposomal Amphotericin B in Treating Granulocytopenia and Persistent Unexplained Fever in Cancer Patients Completed NCT00003938 Phase 3 liposomal amphotericin B
12 Itraconazole Compared With Fluconazole to Prevent Infections in Patients Undergoing Peripheral Stem Cell or Bone Marrow Transplantation Completed NCT00003883 Phase 3 fluconazole;itraconazole
13 Valacyclovir in Preventing Cytomegalovirus Infection in Patients Who Are Undergoing Donor Stem Cell Transplantation Completed NCT00045292 Phase 3 acyclovir;acyclovir sodium;valacyclovir
14 Methotrexate Single-dose Treatment and Methotrexate/Actinomycin-D Single-dose Treatment in Low-Risk Gestational Trophoblastic Neoplasia Active, not recruiting NCT01823315 Phase 3 MTX 1;MTX 2
15 Dactinomycin or Methotrexate in Treating Patients With Low-Risk Gestational Trophoblastic Neoplasia Active, not recruiting NCT01535053 Phase 3 Leucovorin Calcium;Methotrexate
16 Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor Not yet recruiting NCT02639650 Phase 3 Etoposide;actinomycin D;methotrexate;vincristine;cyclophosphamide;Paclitaxel;Cisplatin;Carboplatin
17 Rescue Regimen and High Dose Methotrexate in Management of Presistent Gestational Trophoplastic Neoplasia Not yet recruiting NCT03280979 Phase 2, Phase 3 rescue regimen;high dose methotrxate
18 Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00324324 Phase 3 moxifloxacin hydrochloride;Placebo
19 Mycophenolate Mofetil (MMF) for Treatment of Chronic Graft-versus-host Disease (GVHD) Terminated NCT00089141 Phase 3 mycophenolate mofetil;placebo
20 Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia Completed NCT00003688 Phase 2
21 A Trial for Patients With Gestational Trophoblastic Disease Completed NCT00190918 Phase 2 Pemetrexed
22 Second Curettage in Treating Patients With Persistent Non-metastatic Gestational Trophoblastic Tumors Completed NCT00521118 Phase 2
23 Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell Transplant Completed NCT00410657 Phase 2 methylprednisolone;prednisone
24 Interleukin-11 Plus Filgrastim Prior to Peripheral Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma, Hodgkin's Disease, Breast Cancer, or Other Solid Tumors Completed NCT00004157 Phase 2
25 Campath-1H + FK506 and Methylprednisolone for GVHD Completed NCT00109993 Phase 2 methylprednisolone;tacrolimus
26 Lymphocyte Infusion in Treating Patients With Relapsed Cancer After Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00003887 Phase 2
27 Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon Completed NCT00010283 Phase 1, Phase 2 beclomethasone dipropionate
28 Ravuconazole in Preventing Fungal Infections in Patients Undergoing Allogeneic Stem Cell Transplantation Completed NCT00064311 Phase 1, Phase 2 ravuconazole
29 Biological Therapy Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Cancer Completed NCT00003408 Phase 2
30 Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant Completed NCT00795769 Phase 2 ondansetron
31 Methotrexate and Glucocorticoids in Treating Patients With Newly Diagnosed Acute Graft-Versus-Host Disease After Donor Stem Cell Transplant Completed NCT00357084 Phase 2 methotrexate;methylprednisolone;prednisone
32 Caspofungin Acetate in Treating Aspergillosis in Patients With Hematologic Cancer or in Patients Who Have Undergone a Stem Cell Transplant Completed NCT00110045 Phase 2 caspofungin acetate
33 Immunotherapy in Treating Patients Who Are Undergoing Bone Marrow or Peripheral Stem Cell Transplantation Completed NCT00002673 Phase 2
34 Avelumab in Chemo-resistant Gestational Trophoblastic Neoplasias Recruiting NCT03135769 Phase 2 Avelumab administration at 10mg/kg
35 Study of TRC105 and Bevacizumab in Patients With Refractory Gestational Trophoblastic Neoplasia (GTN) Recruiting NCT02664961 Phase 2 TRC105;Bevacizumab
36 Psychosexual Intervention in Patients With Stage I-III Gynecologic or Breast Cancer Recruiting NCT01764802 Phase 2
37 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors Recruiting NCT02834013 Phase 2
38 Pemetrexed Disodium in Treating Patients With Recurrent or Persistent Low-Risk Gestational Trophoblastic Tumor After a Molar Pregnancy Terminated NCT00096187 Phase 2 pemetrexed disodium
39 Deferasirox for Treating Patients Who Have Undergone Allogeneic Stem Cell Transplant and Have Iron Overload Terminated NCT01159067 Phase 2 deferasirox
40 Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions Unknown status NCT00066404 Phase 1
41 Emergency Use of Donor Lymphocytes in Treating Patients Who Have Undergone Donor Stem Cell Transplant and Have Cytomegalovirus Infections Unknown status NCT00769613 Phase 1
42 Interleukin-12 in Treating Patients With Hematologic Cancers or Solid Tumors Completed NCT00003107 Phase 1
43 Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia Completed NCT01484015 Phase 1 cefepime hydrochloride
44 Aminocamptothecin in Treating Patients With Advanced Cancer of the Peritoneal Cavity Completed NCT00003548 Phase 1 aminocamptothecin colloidal dispersion
45 Colony-Stimulating Factors in Treating Children With Recurrent or Refractory Solid Tumors Completed NCT00003597 Phase 1 carboplatin;etoposide;ifosfamide
46 Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant Completed NCT00569283 Phase 1
47 Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy Completed NCT00509691 Phase 1
48 Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant Completed NCT00361049 Phase 1
49 Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant Terminated NCT00957736 Phase 1
50 Detection of Human Chorionic Gonadotropin by Interferometry in Gestational Trophoblastic Disease Unknown status NCT00166790 chemotherapy agents

Search NIH Clinical Center for Gestational Trophoblastic Neoplasm

Cochrane evidence based reviews: hydatidiform mole

Genetic Tests for Gestational Trophoblastic Neoplasm

Anatomical Context for Gestational Trophoblastic Neoplasm

MalaCards organs/tissues related to Gestational Trophoblastic Neoplasm:

38
Bone, Bone Marrow, Breast, Colon, T Cells, Liver, Small Intestine

Publications for Gestational Trophoblastic Neoplasm

Articles related to Gestational Trophoblastic Neoplasm:

(show all 20)
# Title Authors Year
1
A pilot randomized controlled clinical trial of second uterine curettage versus usual care to determine the effect of re-curettage on patients' need for chemotherapy among women with low risk, nonmetastatic gestational trophoblastic neoplasm in Urmia, Iran. ( 29033610 )
2017
2
Unusual Presentation of Hypothyroidism in a Pregnant Woman, Mimicking Gestational Trophoblastic Neoplasm. ( 27034864 )
2016
3
Tegafur Substitution for 5-Fu in Combination with Actinomycin D to Treat Gestational Trophoblastic Neoplasm. ( 26599757 )
2015
4
Klippel-Trenaunay syndrome and gestational trophoblastic neoplasm. ( 25228614 )
2014
5
A well-circumscribed border with peripheral Doppler signal in sonographic image distinguishes epithelioid trophoblastic tumor from other gestational trophoblastic neoplasms. ( 25396428 )
2014
6
Uterine rupture due to invasive metastatic gestational trophoblastic neoplasm. ( 24106538 )
2013
7
Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study. ( 22055909 )
2012
8
Patients with presenting unusual manifestations with gestational trophoblastic neoplasm: case series and review of literatures. ( 17940785 )
2008
9
Two rare cases of methotrexate-induced pneumonitis and pleurisy in patients with gestational trophoblastic neoplasms. ( 18714577 )
2008
10
Successful treatment of two patients with gestational trophoblastic neoplasm presenting with emergent neurologic symptoms. ( 16681792 )
2006
11
Successful treatment of a patient with gestational trophoblastic neoplasm metastatic to the colon. ( 16263566 )
2005
12
MR appearance of placental site gestational trophoblastic neoplasm. ( 8846312 )
1996
13
[Immunocytochemical localization of human chorionic gonadotropin and placental lactogen in gestational trophoblastic neoplasms]. ( 1337871 )
1992
14
Successful treatment of refractory gestational trophoblastic neoplasm with high-dose etoposide and cyclophosphamide. ( 1661266 )
1991
15
Gestational trophoblastic neoplasm of the uterus: MR assessment. ( 3020607 )
1986
16
Metastatic gestational trophoblastic neoplasm. A study of two cases in unusual clinical settings and review of the literature. ( 6094315 )
1984
17
Epidemiology of gestational trophoblastic neoplasm at the Dr. Cipto Mangunkusumo Hospital, Jakarta, Indonesia. ( 6093460 )
1984
18
Monitor of chemotherapy in gestational trophoblastic neoplasm by radioimmunoassay of the beta-subunit of human chorionic gonadotropin. ( 46716 )
1975
19
Radioimmunoassay of the beta-subunit of human chorionic gonadotropin, monitor of chemotherapy in gestational trophoblastic neoplasm. ( 4377042 )
1973
20
Partial placenta accreta in pregnancies following chemotherapy for gestational trophoblastic neoplasms. ( 4332357 )
1972

Variations for Gestational Trophoblastic Neoplasm

ClinVar genetic disease variations for Gestational Trophoblastic Neoplasm:

6 (show all 13)
# Gene Variation Type Significance SNP ID Assembly Location
1 NLRP7 NLRP7, 14-BP DUP, NT939 duplication Pathogenic
2 NLRP7 NM_001127255.1(NLRP7): c.2030delT (p.Leu677Profs) deletion Pathogenic rs104895554 GRCh37 Chromosome 19, 55449511: 55449511
3 NLRP7 NM_001127255.1(NLRP7): c.337_338insG (p.Glu113Glyfs) insertion Pathogenic rs104895553 GRCh37 Chromosome 19, 55452314: 55452314
4 NLRP7 NM_001127255.1(NLRP7): c.352+1G> A single nucleotide variant Pathogenic rs104895504 GRCh37 Chromosome 19, 55452298: 55452298
5 NLRP7 NM_001127255.1(NLRP7): c.2471+1G> A single nucleotide variant Pathogenic rs104895505 GRCh37 Chromosome 19, 55445856: 55445856
6 NLRP7 NM_001127255.1(NLRP7): c.2077C> T (p.Arg693Trp) single nucleotide variant Pathogenic rs104895506 GRCh37 Chromosome 19, 55449464: 55449464
7 NLRP7 NM_001127255.1(NLRP7): c.2078G> C (p.Arg693Pro) single nucleotide variant Pathogenic rs104895502 GRCh37 Chromosome 19, 55449463: 55449463
8 NLRP7 NM_001127255.1(NLRP7): c.2738A> G (p.Asn913Ser) single nucleotide variant Pathogenic rs104895503 GRCh37 Chromosome 19, 55441939: 55441939
9 NLRP7 NM_001127255.1(NLRP7): c.1294C> T (p.Arg432Ter) single nucleotide variant Pathogenic rs104895530 GRCh37 Chromosome 19, 55450893: 55450893
10 NLRP7 NLRP7, 1-BP INS, 337G insertion Pathogenic
11 NLRP7 NM_001127255.1(NLRP7): c.2078G> A (p.Arg693Gln) single nucleotide variant Pathogenic rs104895502 GRCh37 Chromosome 19, 55449463: 55449463
12 NLRP7 NM_001127255.1(NLRP7): c.1193T> G (p.Leu398Arg) single nucleotide variant Pathogenic rs104895548 GRCh37 Chromosome 19, 55450994: 55450994
13 NLRP7 NM_001127255.1(NLRP7): c.1951C> T (p.Pro651Ser) single nucleotide variant Pathogenic rs104895549 GRCh37 Chromosome 19, 55449590: 55449590

Expression for Gestational Trophoblastic Neoplasm

Search GEO for disease gene expression data for Gestational Trophoblastic Neoplasm.

Pathways for Gestational Trophoblastic Neoplasm

Pathways related to Gestational Trophoblastic Neoplasm according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.24 NLRP2 NLRP7

GO Terms for Gestational Trophoblastic Neoplasm

Sources for Gestational Trophoblastic Neoplasm

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....